| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 7.23e-06 | 5 | 181 | 3 | GO:0140444 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 5.91e-05 | 9 | 181 | 3 | GO:0003810 | |
| GeneOntologyMolecularFunction | choline-phosphate cytidylyltransferase activity | 8.17e-05 | 2 | 181 | 2 | GO:0004105 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic pyrimidine-rich binding | 8.17e-05 | 2 | 181 | 2 | GO:0097158 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.52e-04 | 12 | 181 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 4.84e-04 | 4 | 181 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | histone H3K36me/H3K36me2 demethylase activity | 4.84e-04 | 4 | 181 | 2 | GO:0140680 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.12e-04 | 43 | 181 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 7.28e-04 | 45 | 181 | 4 | GO:0043495 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 2.60e-06 | 4 | 180 | 3 | GO:0043578 | |
| GeneOntologyCellularComponent | sarcomere | MYOM1 SYNE1 NEB RYR1 KCTD6 UNC45B SYNE2 SCN8A MYOM2 PALLD MYBPC2 | 1.10e-05 | 249 | 180 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | MYOM1 SYNE1 NEB RYR1 KCTD6 UNC45B SYNE2 SCN8A MYOM2 PALLD MYBPC2 | 2.59e-05 | 273 | 180 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYOM1 SYNE1 NEB RYR1 KCTD6 UNC45B SYNE2 SCN8A MYOM2 PALLD MYBPC2 | 4.50e-05 | 290 | 180 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | A band | 8.38e-05 | 52 | 180 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 9.85e-05 | 11 | 180 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 9.85e-05 | 11 | 180 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 9.85e-05 | 11 | 180 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 9.85e-05 | 11 | 180 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | M band | 1.39e-04 | 31 | 180 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | nuclear pore inner ring | 2.20e-04 | 3 | 180 | 2 | GO:0044611 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.30e-04 | 107 | 180 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | Rab-protein geranylgeranyltransferase complex | 4.37e-04 | 4 | 180 | 2 | GO:0005968 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 5.05e-04 | 43 | 180 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | myosin filament | 1.26e-03 | 25 | 180 | 3 | GO:0032982 | |
| Domain | Ig_I-set | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD MYBPC2 | 2.27e-06 | 190 | 179 | 11 | IPR013098 |
| Domain | I-set | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD MYBPC2 | 2.27e-06 | 190 | 179 | 11 | PF07679 |
| Domain | IGc2 | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 2.90e-06 | 235 | 179 | 12 | SM00408 |
| Domain | Ig_sub2 | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 2.90e-06 | 235 | 179 | 12 | IPR003598 |
| Domain | Spectrin | 6.26e-05 | 23 | 179 | 4 | PF00435 | |
| Domain | ACTININ_2 | 6.26e-05 | 23 | 179 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.26e-05 | 23 | 179 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.26e-05 | 23 | 179 | 4 | IPR001589 | |
| Domain | Transglut_N | 6.97e-05 | 9 | 179 | 3 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 6.97e-05 | 9 | 179 | 3 | PS00547 | |
| Domain | - | 6.97e-05 | 9 | 179 | 3 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 6.97e-05 | 9 | 179 | 3 | IPR023608 | |
| Domain | Transglutaminase_AS | 6.97e-05 | 9 | 179 | 3 | IPR013808 | |
| Domain | Transglutaminase_N | 6.97e-05 | 9 | 179 | 3 | IPR001102 | |
| Domain | Transglut_C | 6.97e-05 | 9 | 179 | 3 | PF00927 | |
| Domain | Rab_escort | 9.13e-05 | 2 | 179 | 2 | IPR001738 | |
| Domain | Transglutaminase_C | 9.89e-05 | 10 | 179 | 3 | IPR008958 | |
| Domain | - | 1.03e-04 | 26 | 179 | 4 | 4.10.60.10 | |
| Domain | Transglutaminase-like | 1.35e-04 | 11 | 179 | 3 | IPR002931 | |
| Domain | TGc | 1.35e-04 | 11 | 179 | 3 | SM00460 | |
| Domain | Transglut_core | 1.35e-04 | 11 | 179 | 3 | PF01841 | |
| Domain | Spectrin_repeat | 1.61e-04 | 29 | 179 | 4 | IPR002017 | |
| Domain | SPEC | 2.38e-04 | 32 | 179 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.38e-04 | 32 | 179 | 4 | IPR018159 | |
| Domain | PHD_4 | 2.72e-04 | 3 | 179 | 2 | PF16866 | |
| Domain | GPCR_3_CS | 2.92e-04 | 14 | 179 | 3 | IPR017979 | |
| Domain | ZF_CCHC | 3.39e-04 | 35 | 179 | 4 | PS50158 | |
| Domain | ANF_lig-bd_rcpt | 4.21e-04 | 37 | 179 | 4 | IPR001828 | |
| Domain | ANF_receptor | 4.21e-04 | 37 | 179 | 4 | PF01094 | |
| Domain | Ig-like_fold | SEMA4B FLT1 MYOM1 NCAM2 TRIM71 TGM6 F13A1 TGM5 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 4.61e-04 | 706 | 179 | 17 | IPR013783 |
| Domain | Peripla_BP_I | 5.16e-04 | 39 | 179 | 4 | IPR028082 | |
| Domain | Neural_cell_adh | 5.41e-04 | 4 | 179 | 2 | IPR009138 | |
| Domain | KASH | 5.41e-04 | 4 | 179 | 2 | IPR012315 | |
| Domain | KASH | 5.41e-04 | 4 | 179 | 2 | PS51049 | |
| Domain | KASH | 5.41e-04 | 4 | 179 | 2 | SM01249 | |
| Domain | GDI | 5.41e-04 | 4 | 179 | 2 | PF00996 | |
| Domain | KASH | 5.41e-04 | 4 | 179 | 2 | PF10541 | |
| Domain | GDP_dissociation_inhibitor | 5.41e-04 | 4 | 179 | 2 | IPR018203 | |
| Domain | - | 5.97e-04 | 71 | 179 | 5 | 1.10.418.10 | |
| Domain | - | FLT1 MYOM1 NCAM2 TRIM71 TGM6 F13A1 TGM5 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 6.63e-04 | 663 | 179 | 16 | 2.60.40.10 |
| Domain | CH | 6.78e-04 | 73 | 179 | 5 | PS50021 | |
| Domain | CH-domain | 7.67e-04 | 75 | 179 | 5 | IPR001715 | |
| Domain | IG | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 7.74e-04 | 421 | 179 | 12 | SM00409 |
| Domain | Ig_sub | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD LILRA5 MYBPC2 | 7.74e-04 | 421 | 179 | 12 | IPR003599 |
| Domain | fn3 | 9.68e-04 | 162 | 179 | 7 | PF00041 | |
| Domain | GPCR_3 | 1.01e-03 | 21 | 179 | 3 | IPR000337 | |
| Domain | 7tm_3 | 1.17e-03 | 22 | 179 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.17e-03 | 22 | 179 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.17e-03 | 22 | 179 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.17e-03 | 22 | 179 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.17e-03 | 22 | 179 | 3 | PS50259 | |
| Domain | GPCR_3_C | 1.17e-03 | 22 | 179 | 3 | IPR017978 | |
| Domain | zf-CCHC | 1.33e-03 | 23 | 179 | 3 | PF00098 | |
| Domain | GF_recep_IV | 1.34e-03 | 6 | 179 | 2 | PF14843 | |
| Domain | GF_recep_IV | 1.34e-03 | 6 | 179 | 2 | IPR032778 | |
| Domain | ITI_HC_C | 1.34e-03 | 6 | 179 | 2 | IPR010600 | |
| Domain | - | 1.34e-03 | 6 | 179 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.34e-03 | 6 | 179 | 2 | PF00930 | |
| Domain | Peptidase_S9B_N | 1.34e-03 | 6 | 179 | 2 | IPR002469 | |
| Domain | ITI_HC_C | 1.34e-03 | 6 | 179 | 2 | PF06668 | |
| Domain | JmjC | 1.51e-03 | 24 | 179 | 3 | PF02373 | |
| Domain | CTP_transf_like | 1.86e-03 | 7 | 179 | 2 | PF01467 | |
| Domain | Cyt_trans-like | 1.86e-03 | 7 | 179 | 2 | IPR004821 | |
| Domain | ZnF_C2HC | 1.90e-03 | 55 | 179 | 4 | SM00343 | |
| Domain | Znf_CCHC | 1.90e-03 | 55 | 179 | 4 | IPR001878 | |
| Domain | FN3 | 2.08e-03 | 185 | 179 | 7 | SM00060 | |
| Domain | GPCR_3_mtglu_rcpt | 2.46e-03 | 8 | 179 | 2 | IPR000162 | |
| Domain | VIT | 2.46e-03 | 8 | 179 | 2 | PF08487 | |
| Domain | VIT | 2.46e-03 | 8 | 179 | 2 | SM00609 | |
| Domain | RASGEF_CAT | 2.63e-03 | 29 | 179 | 3 | PS50009 | |
| Pubmed | CAD DSC2 OFD1 BCLAF1 SYNE1 SF3A1 MINK1 NOC3L DNAJC27 ME2 TRIP4 TMCC3 DDX10 NEO1 NUP155 SND1 PIK3C2A SUN2 PPP1R15B SYNE2 EIF2B4 NFXL1 PRKAR2A MACF1 PNPLA8 SLC30A9 RBM34 FTSJ3 | 3.91e-09 | 1487 | 181 | 28 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TOM1L2 CAD MYO1D CENPE ACOT9 RBM4 SYNE1 PSMB4 RNF213 ZCCHC17 IDE WRAP53 CHML ME2 SF1 TMCC3 NUP155 SND1 PIK3C2A SUN2 PPP1R15B SYNE2 PRKAR2A PNPLA8 NUP188 SLC30A9 RBM34 FTSJ3 | 4.46e-09 | 1496 | 181 | 28 | 32877691 |
| Pubmed | MYOM1 KDM5A SYNE1 SPTB SAMHD1 NEB SF1 RYR1 NEO1 PIK3C2A SYNE2 MACF1 KDM2A MYOM2 PALLD MYBPC2 | 8.80e-09 | 497 | 181 | 16 | 23414517 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ERCC3 MYO1D KDM5A ACOT9 BCLAF1 ACLY RBM4 MINK1 TRIP4 SF1 DDX10 SND1 PIK3C2A SYTL4 PRKAA1 NFXL1 MACF1 KDM2A PALLD | 9.30e-09 | 724 | 181 | 19 | 36232890 |
| Pubmed | TPR RRAS2 CAD ERCC3 MYO1D ACOT9 BCLAF1 ACLY SF3A1 PSMB4 SAMHD1 TRIP4 SF1 RCOR1 PIK3C2A FDPS SUN2 KDM2B PRKAR2A EIF3I MED27 CAMSAP2 RPAP2 FTSJ3 | 3.79e-08 | 1247 | 181 | 24 | 27684187 | |
| Pubmed | DHX16 TPR CAD MYO1D ACLY SF3A1 NOC3L ME2 DDX10 NUP155 SND1 SYNE2 MACF1 NUP188 EIF3I RBM34 FTSJ3 | 6.55e-08 | 653 | 181 | 17 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 TPR RRAS2 CAD OFD1 MYO1D BCLAF1 RBM4B ACLY RBM4 SYNE1 SF3A1 SF1 DDX10 NUP155 SND1 SYNE2 PRKAA1 MACF1 NUP188 FTSJ3 | 1.01e-07 | 1024 | 181 | 21 | 24711643 |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 3.40e-07 | 12 | 181 | 4 | 8618961 | |
| Pubmed | SEMA4B RNF213 PTPN23 CNNM4 SAMD9L SUN2 SPON1 TBC1D12 MACF1 KDM2A TTC39A PLEKHH2 PALLD DOP1A | 3.54e-07 | 493 | 181 | 14 | 15368895 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 TPR CAD MYO1D BCLAF1 ACLY RBM4 SYNE1 SF3A1 NOC3L SAMHD1 IDE ME2 SF1 DDX10 NUP155 SND1 PRKAR2A PNPLA8 NUP188 EIF3I BSN RBM34 FTSJ3 | 4.33e-07 | 1425 | 181 | 24 | 30948266 |
| Pubmed | 4.64e-07 | 234 | 181 | 10 | 36243803 | ||
| Pubmed | Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase. | 5.52e-07 | 4 | 181 | 3 | 21939789 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 5.52e-07 | 4 | 181 | 3 | 20108321 | |
| Pubmed | 7.18e-07 | 189 | 181 | 9 | 31594818 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 TPR RRAS2 CAD ERCC3 MYO1D ACOT9 BCLAF1 ACLY SF3A1 BTBD10 NOC3L LAMA3 SF1 ITIH2 NUP155 SND1 SUN2 EIF2B4 EIF3I RBM34 FTSJ3 | 7.27e-07 | 1257 | 181 | 22 | 36526897 |
| Pubmed | DHX16 ERCC3 KDM5A BCLAF1 RBM4B ACLY SF3A1 TRIM71 ZCCHC17 SAMHD1 WRAP53 TRIP4 SF1 ITIH2 DDX10 PIK3C2A PCSK6 EIF2B4 MED27 MUC5AC SH3BGRL3 RBM34 FTSJ3 | 8.24e-07 | 1371 | 181 | 23 | 36244648 | |
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 1.38e-06 | 5 | 181 | 3 | 22632968 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 18396275 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TOM1L2 GLT8D1 DSC2 ACLY PSMB4 SPCS2 NOC3L SAMHD1 DDX10 CNNM4 NUP155 SND1 PCSK6 EIF2B4 NFXL1 PRKAR2A NUP188 SLC30A9 | 2.37e-06 | 942 | 181 | 18 | 31073040 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 TPR RRAS2 CAD ERCC3 ACLY PSMB4 NOC3L PTPN23 DDX10 NUP155 SND1 PIK3C2A FDPS EIF2B4 NFXL1 MACF1 KDM2A EIF3I PALLD RBM34 FTSJ3 | 2.42e-06 | 1353 | 181 | 22 | 29467282 |
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 2.74e-06 | 6 | 181 | 3 | 33058875 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB4 RAPGEF6 DSC2 OFD1 KDM5A MINK1 DPP8 TMCC3 FAM13A PIK3C2A SYNE2 MACF1 EIF3I CAMSAP2 PALLD ABTB2 DOP1A | 2.97e-06 | 861 | 181 | 17 | 36931259 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | CAD ERCC3 BCLAF1 NOC3L TRIP4 NUP155 SND1 TBC1D12 NUP188 MED27 RPAP2 FTSJ3 | 3.76e-06 | 440 | 181 | 12 | 34244565 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | RRAS2 CAD MYO1D RBM4B ACLY SF3A1 PSMB4 SAMHD1 SND1 EIF2B4 EIF3I MED27 SH3BGRL3 RPAP2 | 5.53e-06 | 624 | 181 | 14 | 33729478 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DHX16 BCLAF1 RBM4B RBM4 SYNE1 SF3A1 NOC3L DUSP14 CPEB3 ZCCHC17 SF1 DDX10 SND1 MACF1 RBM34 FTSJ3 | 5.59e-06 | 807 | 181 | 16 | 22681889 |
| Pubmed | 6.65e-06 | 187 | 181 | 8 | 26460568 | ||
| Pubmed | TPR CAD ERCC3 BCLAF1 ACLY RBM4 SF1 NUP155 SND1 PIK3C2A MACF1 KDM2A NUP188 SH3BGRL3 | 1.04e-05 | 660 | 181 | 14 | 32780723 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DHX16 TPR PCYT1A RRAS2 CENPE ACOT9 BCLAF1 SYNE1 SF3A1 IDE WRAP53 RCOR1 NUP155 SYTL4 IFFO2 PRKAR2A NUP188 EIF3I TTC33 | 1.05e-05 | 1155 | 181 | 19 | 20360068 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DPP6 RASA1 RBM4 SPTB MINK1 LAMA3 RNF213 NCAM2 IDE PFKFB4 ADGRV1 ME2 PLEKHH1 CNNM4 PTPN4 FAM13A EIF2B4 MACF1 KDM2A MED27 DOP1A RPAP2 | 1.10e-05 | 1489 | 181 | 22 | 28611215 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC3 CENPE RBM4 BTBD10 NOC3L ZCCHC17 SAMHD1 DDX10 NUP155 SND1 EIF2B4 MACF1 EIF3I RBM34 FTSJ3 | 1.15e-05 | 759 | 181 | 15 | 35915203 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.32e-05 | 341 | 181 | 10 | 32971831 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RRAS2 ACLY PSMB4 SPCS2 DUSP14 PTPN23 SAMHD1 IDE CNNM4 PTPN4 RCOR1 NUP155 EIF2B4 PRKAA1 PNMA2 NUP188 ABTB2 | 1.48e-05 | 974 | 181 | 17 | 28675297 |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.62e-05 | 10 | 181 | 3 | 28533284 | |
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 1.62e-05 | 10 | 181 | 3 | 12958361 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 1.62e-05 | 10 | 181 | 3 | 20368620 | |
| Pubmed | 1.63e-05 | 102 | 181 | 6 | 21926972 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.01e-05 | 358 | 181 | 10 | 32460013 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYOM1 DSC2 CENPE BCLAF1 ZCCHC17 GRM6 SAMD9L MACF1 DNAH6 PALLD | 2.16e-05 | 361 | 181 | 10 | 26167880 |
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 2.28e-05 | 32 | 181 | 4 | 37067297 | |
| Pubmed | 2.54e-05 | 225 | 181 | 8 | 12168954 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 10480912 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 11792814 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32901907 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.69e-05 | 2 | 181 | 2 | 24931616 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31526569 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 9175730 | ||
| Pubmed | Involvement of Rab27b in the regulated secretion of pituitary hormones. | 2.69e-05 | 2 | 181 | 2 | 11956164 | |
| Pubmed | Phylogenetic and molecular characterization of the splicing factor RBM4. | 2.69e-05 | 2 | 181 | 2 | 23527094 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23506848 | ||
| Pubmed | Coiled-Coil Domains of SUN Proteins as Intrinsic Dynamic Regulators. | 2.69e-05 | 2 | 181 | 2 | 26688217 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22768332 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 23431139 | ||
| Pubmed | Biological Functions of the KDM2 Family of Histone Demethylases. | 2.69e-05 | 2 | 181 | 2 | 37751135 | |
| Pubmed | The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum. | 2.69e-05 | 2 | 181 | 2 | 18708123 | |
| Pubmed | Linear arrays of nuclear envelope proteins harness retrograde actin flow for nuclear movement. | 2.69e-05 | 2 | 181 | 2 | 20724637 | |
| Pubmed | Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes. | 2.69e-05 | 2 | 181 | 2 | 29929979 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.69e-05 | 2 | 181 | 2 | 17267447 | |
| Pubmed | ELL, a novel TFIIH partner, is involved in transcription restart after DNA repair. | 2.69e-05 | 2 | 181 | 2 | 24127601 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.69e-05 | 2 | 181 | 2 | 24718612 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 24586179 | ||
| Pubmed | Cloning and characterization of the human choroideremia gene. | 2.69e-05 | 2 | 181 | 2 | 7981670 | |
| Pubmed | Bassoon inhibits proteasome activity via interaction with PSMB4. | 2.69e-05 | 2 | 181 | 2 | 32651614 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22357859 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17761684 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31578382 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 31363749 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 32186954 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17545167 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 38520674 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 26165797 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 12842190 | ||
| Pubmed | Clericuzio-type poikiloderma with neutropenia in a patient from India. | 2.69e-05 | 2 | 181 | 2 | 33111394 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | GLT8D1 ACOT9 ACLY MCL1 IDE CNNM4 KCTD6 PTPN4 SND1 PNMA2 PRKAR2A ABTB2 RBM34 VCPKMT RPAP2 FTSJ3 | 3.21e-05 | 931 | 181 | 16 | 27432908 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR RAPGEF6 BCLAF1 ACLY SF3A1 NOC3L PTPN23 ME2 SF1 DDX10 SND1 MACF1 EIF3I CAMSAP2 PALLD FTSJ3 | 3.34e-05 | 934 | 181 | 16 | 33916271 |
| Pubmed | 3.34e-05 | 304 | 181 | 9 | 32235678 | ||
| Pubmed | TPR CAD RAPGEF6 BCLAF1 ACLY PTPN23 SND1 KDM2B KDM2A MED27 PALLD RPAP2 | 3.38e-05 | 549 | 181 | 12 | 38280479 | |
| Pubmed | CAD OFD1 MYO1D MINK1 NOC3L DUSP14 RNF213 PTPN23 IDE CNNM4 PTPN4 NUP155 SUN2 SYNE2 PNMA2 TTC33 FTSJ3 | 3.77e-05 | 1049 | 181 | 17 | 27880917 | |
| Pubmed | 3.82e-05 | 13 | 181 | 3 | 21177258 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TOM1L2 ERCC3 OFD1 ACOT9 IDE TRIP4 DDX10 SND1 SUN2 PCSK6 PRKAR2A EIF3I SLC30A9 FTSJ3 | 4.47e-05 | 754 | 181 | 14 | 33060197 |
| Pubmed | TPR CAD CENPE KDM5A BCLAF1 SYNE1 MINK1 GABBR2 GRM4 RCOR1 SYNE2 PRKAR2A MACF1 ELAVL4 BSN CAMSAP2 | 4.80e-05 | 963 | 181 | 16 | 28671696 | |
| Pubmed | 4.84e-05 | 14 | 181 | 3 | 19874786 | ||
| Pubmed | DHX16 PCYT1A CAD GLT8D1 ACLY PSMB4 SPCS2 PTPN23 NUP155 ISG15 SND1 SYNE2 PRKAR2A MACF1 KDM2A NUP188 PALLD GNS RBM34 | 5.09e-05 | 1297 | 181 | 19 | 33545068 | |
| Pubmed | RRAS2 CAD MYO1D ACLY RBM4 SPCS2 CNNM4 NUP155 SND1 PRKAA1 NUP188 | 5.10e-05 | 484 | 181 | 11 | 31995728 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR PCYT1A CAD ACOT9 ACLY RBM4 SF3A1 PTPN23 SF1 KCTD6 NUP155 SND1 SYNE2 EIF2B4 PRKAA1 MACF1 EIF3I PALLD RPAP2 FTSJ3 | 5.25e-05 | 1415 | 181 | 20 | 28515276 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | PCYT1A MYO1D BCLAF1 SF3A1 SAMHD1 ITIH5 RCOR1 SUN2 C2orf42 NUP188 EIF3I PALLD RPAP2 | 5.40e-05 | 670 | 181 | 13 | 22990118 |
| Pubmed | TOM1L2 SLC43A2 TPR SCRN3 RAPGEF6 RIPPLY3 SPCS2 PTPN23 PTCH1 ME2 F13A1 RCOR1 P2RX4 PRKAA1 NFXL1 MACF1 NUP188 | 5.65e-05 | 1084 | 181 | 17 | 11544199 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 5.87e-05 | 327 | 181 | 9 | 15592455 | |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 6.02e-05 | 15 | 181 | 3 | 22797597 | |
| Pubmed | TOM1L2 DPP6 CAD MYO1D BCLAF1 ACLY SYNE1 SPTB MINK1 NCAM2 TENM4 SND1 SPON1 NMT2 PRKAA1 PRKAR2A MACF1 BSN CAMSAP2 DNAH6 | 6.13e-05 | 1431 | 181 | 20 | 37142655 | |
| Pubmed | 6.60e-05 | 332 | 181 | 9 | 25693804 | ||
| Pubmed | CAD BCLAF1 PSMB4 NOC3L RNF213 SAMHD1 SF1 CNNM4 NUP155 SND1 PIK3C2A FDPS SUN2 SYNE2 EIF2B4 NUP188 EIF3I SLC30A9 GNS RBM34 | 6.68e-05 | 1440 | 181 | 20 | 30833792 | |
| Pubmed | GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling. | 7.39e-05 | 16 | 181 | 3 | 26932670 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | TPR SEMA4B RRAS2 DSC2 ACOT9 ACLY SF3A1 SPCS2 MCL1 RNF213 PTPN23 ME2 F13A1 NEO1 NUP155 ISG15 SND1 PRKAA1 DNAH6 CSGALNACT1 | 7.40e-05 | 1451 | 181 | 20 | 30550785 |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 23883584 | ||
| Pubmed | De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus. | 8.05e-05 | 3 | 181 | 2 | 29983323 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 30033217 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 8.05e-05 | 3 | 181 | 2 | 16079285 | |
| Pubmed | Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. | 8.05e-05 | 3 | 181 | 2 | 19718025 | |
| Pubmed | The amino-terminal domain of glutamate receptor delta2 triggers presynaptic differentiation. | 8.05e-05 | 3 | 181 | 2 | 19000899 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 27821480 | ||
| Cytoband | 11p15.2 | 2.69e-05 | 15 | 182 | 3 | 11p15.2 | |
| Cytoband | 17q11-q12 | 2.32e-04 | 6 | 182 | 2 | 17q11-q12 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | FLT1 MYOM1 NCAM2 CNTN6 NEO1 HMCN1 PXDNL MYOM2 SDK1 PALLD MYBPC2 | 1.67e-08 | 161 | 126 | 11 | 593 |
| GeneFamily | CD molecules|DASH family | 1.13e-05 | 7 | 126 | 3 | 1205 | |
| GeneFamily | Fibronectin type III domain containing | 1.64e-05 | 160 | 126 | 8 | 555 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.80e-05 | 8 | 126 | 3 | 658 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 2.54e-05 | 25 | 126 | 4 | 74 | |
| GeneFamily | Transglutaminases | 2.69e-05 | 9 | 126 | 3 | 773 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.86e-04 | 4 | 126 | 2 | 1252 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.01e-04 | 24 | 126 | 3 | 485 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.31e-03 | 8 | 126 | 2 | 281 | |
| GeneFamily | Nucleoporins | 1.41e-03 | 32 | 126 | 3 | 1051 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.69e-03 | 181 | 126 | 6 | 694 | |
| GeneFamily | Zinc fingers CXXC-type | 3.04e-03 | 12 | 126 | 2 | 136 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.77e-03 | 15 | 126 | 2 | 26 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 4.77e-03 | 15 | 126 | 2 | 858 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.10e-03 | 50 | 126 | 3 | 1293 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 6.85e-03 | 18 | 126 | 2 | 812 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SCRN3 RASA1 BCLAF1 NUDT2 DPP8 TRIP4 DDX10 PTPN4 SAMD9L PIK3C2A TBC1D12 CAMSAP2 PALLD RBM34 PCYT1B TTC33 RPAP2 | 1.61e-07 | 523 | 182 | 17 | M12707 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SCRN3 RASA1 BCLAF1 NUDT2 DPP8 TRIP4 DDX10 PTPN4 SAMD9L PIK3C2A TBC1D12 CAMSAP2 PALLD RBM34 PCYT1B TTC33 RPAP2 | 2.16e-07 | 534 | 182 | 17 | MM1054 |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP | 1.12e-05 | 199 | 182 | 9 | M8744 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | DPP7 DPP6 TRIB2 MNS1 GRID2 PTCH1 GABBR2 KCNIP1 PLEKHH2 DNAH6 CSGALNACT1 | 1.83e-05 | 325 | 182 | 11 | M39053 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_1000 | OFD1 CPEB3 TRIM71 GRID2 NEB TMCC3 ITIH5 TENM4 SYTL4 PCSK6 SYNE2 | 4.49e-09 | 117 | 179 | 11 | gudmap_developingGonad_e18.5_ovary_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_500 | 2.72e-08 | 81 | 179 | 9 | gudmap_developingGonad_e18.5_ovary_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | PRSS35 PCYT1A OFD1 KDM5A PCDHB9 CPEB3 RNF213 TRIM71 GRID2 NEB CHM ME2 TMCC3 ITIH5 DDX10 TENM4 HMCN1 SYTL4 NMT2 PCSK6 SYNE2 ABTB2 | 7.09e-07 | 778 | 179 | 22 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | PRSS35 OFD1 CENPE PCDHB9 CPEB3 RNF213 TRIM71 GRID2 NEB CHM GRM4 ME2 TMCC3 ITIH5 DDX10 TENM4 SYTL4 NMT2 PCSK6 SYNE2 ABTB2 | 2.29e-06 | 770 | 179 | 21 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_200 | 2.50e-06 | 72 | 179 | 7 | gudmap_developingGonad_P2_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_1000 | OFD1 CPEB3 TRIM71 GRID2 NEB GRM4 TMCC3 ITIH5 TENM4 SYTL4 PCSK6 SYNE2 | 5.35e-06 | 283 | 179 | 12 | gudmap_developingGonad_P2_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_500 | 8.03e-06 | 158 | 179 | 9 | gudmap_developingGonad_P2_ovary_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-05 | 93 | 179 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_200 | 1.65e-05 | 132 | 179 | 8 | gudmap_developingGonad_P2_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | PRSS35 OFD1 CPEB3 TRIM71 GRID2 NEB CHM TMCC3 ITIH5 TENM4 SYTL4 PCSK6 SYNE2 | 2.10e-05 | 379 | 179 | 13 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.18e-05 | 179 | 179 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.28e-05 | 138 | 179 | 8 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | OFD1 CPEB3 TRIM71 GRID2 NEB CHM ME2 TMCC3 ITIH5 TENM4 PCSK6 SYNE2 ABTB2 | 2.61e-05 | 387 | 179 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | PRSS35 GADD45B TRIB2 DSC2 MNS1 RNF213 PTCH1 ME2 CNTN6 PTPN4 RCOR1 TENM4 HMCN1 OLFML1 PCSK6 NFXL1 PLEKHH2 PALLD ABTB2 VCPKMT | 3.39e-05 | 849 | 179 | 20 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | PRSS35 GADD45B TRIB2 DSC2 MNS1 MYO1D RNF213 KCNIP1 ME2 CNTN6 PTPN4 RCOR1 NEO1 TENM4 HMCN1 OLFML1 NFXL1 PLEKHH2 PALLD CSGALNACT1 | 3.93e-05 | 858 | 179 | 20 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_200 | 4.55e-05 | 24 | 179 | 4 | gudmap_developingGonad_e18.5_ovary_200_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | PRSS35 DSC2 MNS1 RNF213 SAMHD1 KCNIP1 ME2 CNTN6 PTPN4 RCOR1 NEO1 TENM4 HMCN1 OLFML1 SYTL4 PCSK6 PLEKHH2 PALLD CSGALNACT1 | 4.59e-05 | 797 | 179 | 19 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | PRSS35 DSC2 NOC3L RNF213 KCNIP1 ME2 PTPN4 NEO1 TENM4 P2RX4 HMCN1 OLFML1 PCSK6 SYNE2 NFXL1 PLEKHH2 PALLD CSGALNACT1 | 1.16e-04 | 783 | 179 | 18 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.67e-04 | 233 | 179 | 9 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.80e-04 | 139 | 179 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | PRSS35 DSC2 RNF213 SAMHD1 ME2 PTPN4 NEO1 HMCN1 SYTL4 NMT2 NFXL1 CSGALNACT1 | 2.14e-04 | 414 | 179 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PRSS35 TRIB2 DSC2 CENPE NOC3L RNF213 PTCH1 ME2 CNTN6 NEO1 TENM4 HMCN1 CSRNP3 OLFML1 SYNE2 NFXL1 PLEKHH2 PALLD | 2.27e-04 | 827 | 179 | 18 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SLC43A2 TPR CWF19L2 MNS1 CENPE BCLAF1 TRIM71 GRID2 ADGRV1 CHML CNTN6 PLEKHH1 PTPN4 CSRNP3 GLDC SPON1 SYNE2 PRKAR2A MACF1 ELAVL4 | 2.56e-04 | 986 | 179 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 2.65e-04 | 148 | 179 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PRSS35 ERBB4 TRIB2 CENPE PCDHB10 RNF213 PTCH1 CNTN6 ITIH5 TENM4 HMCN1 OLFML1 FDPS PCSK6 SYNE2 PLEKHH2 PALLD | 3.03e-04 | 773 | 179 | 17 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | SLC43A2 MNS1 CENPE TRIM71 ADGRV1 CHML CNTN6 PLEKHH1 PTPN4 GLDC SYNE2 PRKAR2A ELAVL4 | 3.11e-04 | 496 | 179 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | TRIB2 PTCH1 CNTN6 ITIH5 TENM4 HMCN1 OLFML1 SYNE2 PLEKHH2 PALLD | 3.13e-04 | 310 | 179 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | TPR RRAS2 DSC2 MYO1D PCDHB9 LAMA3 C8orf48 IDE ITIH2 TMCC3 PLEKHH1 SAMD9L NUP155 PIK3C2A SCN8A CAMSAP2 RAB27B | 3.56e-04 | 784 | 179 | 17 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PRSS35 ERBB4 TRIB2 DSC2 MYO1D CENPE RNF213 PTCH1 CNTN6 ITIH5 RCOR1 TENM4 HMCN1 OLFML1 PCSK6 PLEKHH2 PALLD | 4.06e-04 | 793 | 179 | 17 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | PRSS35 GADD45B DSC2 MNS1 RNF213 KCNIP1 ITIH5 PTPN4 NEO1 TENM4 HMCN1 OLFML1 SYTL4 PCSK6 PLEKHH2 PALLD CSGALNACT1 | 4.30e-04 | 797 | 179 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | BM Top 100 - skeletal muscle | 4.31e-04 | 75 | 179 | 5 | BM Top 100 - skeletal muscle | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CWF19L2 GLT8D1 MNS1 CENPE BCLAF1 ACLY NCAM2 NEB ME2 PTPN4 PCSK6 SYNE2 ELAVL4 ABTB2 DOP1A | 4.47e-04 | 654 | 179 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PRSS35 DSC2 RNF213 SAMHD1 ME2 PTPN4 NEO1 FAM13A P2RX4 HMCN1 PIK3C2A SYTL4 NMT2 PCSK6 NFXL1 CSGALNACT1 RPAP2 | 4.68e-04 | 803 | 179 | 17 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 5.11e-04 | 165 | 179 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | RRAS2 DSC2 LAMA3 C8orf48 IDE ITIH2 PLEKHH1 SAMD9L PIK3C2A SCN8A RAB27B | 5.36e-04 | 394 | 179 | 11 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | PRSS35 DSC2 RNF213 ME2 ITIH5 PTPN4 NEO1 TENM4 HMCN1 OLFML1 SYTL4 NMT2 PCSK6 PLEKHH2 PALLD CSGALNACT1 | 5.49e-04 | 740 | 179 | 16 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CWF19L2 MNS1 RASA1 CENPE BCLAF1 ZCCHC17 ME2 TRIP4 PTPN4 NUP155 GLDC NMT2 FTSJ3 | 6.01e-04 | 532 | 179 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 ADGRV1 NEB GALNT13 TENM4 HMCN1 PTPRQ ELAVL4 MYOM2 SDK1 | 4.76e-09 | 184 | 182 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 ADGRV1 NEB GALNT13 TENM4 HMCN1 PTPRQ ELAVL4 MYOM2 SDK1 | 4.76e-09 | 184 | 182 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 ADGRV1 NEB GALNT13 TENM4 HMCN1 PTPRQ ELAVL4 MYOM2 SDK1 | 4.76e-09 | 184 | 182 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | DPP6 NCAM2 GRID2 SAMHD1 HMCN1 SPON1 MACF1 PLEKHH2 SDK1 PALLD | 5.57e-09 | 187 | 182 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | RALGDS SYNE1 RNF213 SAMHD1 PTPN4 SAMD9L ISG15 SUN2 SYNE2 SH3BGRL3 | 9.62e-09 | 198 | 182 | 10 | 3d1749f5106f0912f4a74615863853949f52c73d |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | RALGDS SYNE1 RNF213 SAMHD1 PTPN4 SAMD9L ISG15 SUN2 SYNE2 SH3BGRL3 | 9.62e-09 | 198 | 182 | 10 | 6a28193af35abec5c029129930c2ca6febaafde2 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-08 | 200 | 182 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-08 | 191 | 182 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-07 | 193 | 182 | 9 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-07 | 193 | 182 | 9 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.11e-07 | 194 | 182 | 9 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.11e-07 | 194 | 182 | 9 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-07 | 198 | 182 | 9 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-07 | 198 | 182 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 199 | 182 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.44e-07 | 200 | 182 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.99e-07 | 177 | 182 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 178 | 182 | 8 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-06 | 187 | 182 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 191 | 182 | 8 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-06 | 192 | 182 | 8 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-06 | 192 | 182 | 8 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | ASK452-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.29e-06 | 192 | 182 | 8 | f04ee5aaa54c39b7493098fb3d2f78168d6b8060 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 193 | 182 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 193 | 182 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 194 | 182 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-06 | 194 | 182 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.45e-06 | 195 | 182 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-06 | 195 | 182 | 8 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-06 | 196 | 182 | 8 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-06 | 196 | 182 | 8 | 8e1ed30256a031bb90dac1f167e074c68efbed74 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 197 | 182 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-06 | 197 | 182 | 8 | 4e141dfb094e10383d815fc7108b11a0584c3a4b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-06 | 197 | 182 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-06 | 197 | 182 | 8 | 08286770c0b707a7a4436ea8d4416ddfbfe2dc0c | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.56e-06 | 197 | 182 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 198 | 182 | 8 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-06 | 198 | 182 | 8 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-06 | 198 | 182 | 8 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 1.62e-06 | 198 | 182 | 8 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 198 | 182 | 8 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.62e-06 | 198 | 182 | 8 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 198 | 182 | 8 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 198 | 182 | 8 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-06 | 198 | 182 | 8 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-06 | 198 | 182 | 8 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 199 | 182 | 8 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 199 | 182 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-06 | 199 | 182 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-06 | 199 | 182 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-06 | 199 | 182 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.75e-06 | 200 | 182 | 8 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-06 | 200 | 182 | 8 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-06 | 200 | 182 | 8 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.75e-06 | 200 | 182 | 8 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-06 | 200 | 182 | 8 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-06 | 200 | 182 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.75e-06 | 200 | 182 | 8 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-06 | 200 | 182 | 8 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.75e-06 | 200 | 182 | 8 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 165 | 182 | 7 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.77e-06 | 171 | 182 | 7 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 172 | 182 | 7 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 172 | 182 | 7 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 182 | 7 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 8.48e-06 | 177 | 182 | 7 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 178 | 182 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 181 | 182 | 7 | 145fae2746c5212640b7b11b04a7759ba8e5c322 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 181 | 182 | 7 | a9f1fc5973cffdbeb7d1f5c41534422d85d596ff | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.05e-05 | 183 | 182 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 186 | 182 | 7 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 186 | 182 | 7 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 187 | 182 | 7 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 125 | 182 | 6 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-05 | 189 | 182 | 7 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 190 | 182 | 7 | 86ab845a7fae2111c0b01e1aec235e19c4c0ef5c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 190 | 182 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 190 | 182 | 7 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 191 | 182 | 7 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 191 | 182 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 192 | 182 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 192 | 182 | 7 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-05 | 192 | 182 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.44e-05 | 192 | 182 | 7 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| Disease | unipolar depression, bipolar disorder | 5.30e-06 | 156 | 179 | 8 | EFO_0003761, MONDO_0004985 | |
| Disease | Basal cell carcinoma | 3.49e-05 | 11 | 179 | 3 | C0007117 | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 3.66e-05 | 2 | 179 | 2 | C2751544 | |
| Disease | choroideremia (implicated_via_orthology) | 3.66e-05 | 2 | 179 | 2 | DOID:9821 (implicated_via_orthology) | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 2.18e-04 | 4 | 179 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 2.18e-04 | 4 | 179 | 2 | cv:C2751544 | |
| Disease | B-cell antigen receptor complex-associated protein alpha chain measurement | 2.18e-04 | 4 | 179 | 2 | EFO_0801402 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.18e-04 | 4 | 179 | 2 | cv:CN293514 | |
| Disease | Disorder of eye | 3.27e-04 | 212 | 179 | 7 | C0015397 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.62e-04 | 5 | 179 | 2 | C1450051 | |
| Disease | Cerebellar Ataxia | 3.62e-04 | 5 | 179 | 2 | C0007758 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.62e-04 | 5 | 179 | 2 | C0410190 | |
| Disease | tuberculosis | 3.66e-04 | 216 | 179 | 7 | MONDO_0018076 | |
| Disease | Emery-Dreifuss muscular dystrophy | 5.40e-04 | 6 | 179 | 2 | cv:C0410189 | |
| Disease | spondin-1 measurement | 5.40e-04 | 6 | 179 | 2 | EFO_0008290 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 5.40e-04 | 6 | 179 | 2 | C1854678 | |
| Disease | glucagon measurement, glucose tolerance test | 5.40e-04 | 6 | 179 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 5.40e-04 | 6 | 179 | 2 | C0410189 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.99e-04 | 169 | 179 | 6 | DOID:3908 (is_marker_for) | |
| Disease | NAD-dependent protein deacetylase sirtuin-2 measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0008241 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain H1 measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0801705 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 7.53e-04 | 7 | 179 | 2 | C0751337 | |
| Disease | Hereditary spherocytosis | 1.00e-03 | 8 | 179 | 2 | C0037889 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 1.00e-03 | 8 | 179 | 2 | DOID:5520 (is_marker_for) | |
| Disease | ribose-5-phosphate measurement, ribulose-5-phosphate measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0010529, EFO_0010530 | |
| Disease | CCL2 measurement | 1.05e-03 | 126 | 179 | 5 | EFO_0004749 | |
| Disease | glycine measurement | 1.52e-03 | 137 | 179 | 5 | EFO_0009767 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.53e-03 | 355 | 179 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | hepatocyte growth factor-like protein measurement | 1.58e-03 | 38 | 179 | 3 | EFO_0008154 | |
| Disease | Intellectual Disability | 1.71e-03 | 447 | 179 | 9 | C3714756 | |
| Disease | thalamus volume | 1.81e-03 | 85 | 179 | 4 | EFO_0006935 | |
| Disease | complement factor H measurement | 1.98e-03 | 41 | 179 | 3 | EFO_0008097 | |
| Disease | ovarian reserve | 2.32e-03 | 12 | 179 | 2 | EFO_0004770 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.32e-03 | 12 | 179 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 2.32e-03 | 12 | 179 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | progression free survival, urinary bladder cancer | 2.32e-03 | 12 | 179 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | Abruptio Placentae | 2.32e-03 | 12 | 179 | 2 | EFO_1001754 | |
| Disease | Congenital myopathy (disorder) | 2.32e-03 | 12 | 179 | 2 | C0270960 | |
| Disease | Malignant neoplasm of breast | FLT1 ERBB4 ERCC3 SYNE1 NUDT2 PFKFB4 GRM6 CNTN6 DDX10 CNNM4 UNC45B SYNE2 PRKAA1 MACF1 DOP1A | 2.39e-03 | 1074 | 179 | 15 | C0006142 |
| Disease | immunoglobulin isotype switching measurement | 2.42e-03 | 44 | 179 | 3 | EFO_0010128 | |
| Disease | caudate volume change measurement | 3.17e-03 | 14 | 179 | 2 | EFO_0021491 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.30e-03 | 49 | 179 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | cognitive inhibition measurement | 3.49e-03 | 50 | 179 | 3 | EFO_0007969 | |
| Disease | Dyskeratosis Congenita | 4.15e-03 | 16 | 179 | 2 | C0265965 | |
| Disease | Dupuytren Contracture | 4.30e-03 | 108 | 179 | 4 | EFO_0004229 | |
| Disease | Moyamoya Disease | 4.69e-03 | 17 | 179 | 2 | C0026654 | |
| Disease | calcium measurement | SLC43A2 BTBD10 OFCC1 DUSP14 CNNM4 SND1 SYTL4 SYNE2 EIF2B4 MACF1 | 5.19e-03 | 628 | 179 | 10 | EFO_0004838 |
| Disease | Amyotrophic Lateral Sclerosis | 5.30e-03 | 58 | 179 | 3 | C0002736 | |
| Disease | Malignant neoplasm of skin | 5.56e-03 | 59 | 179 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 5.56e-03 | 59 | 179 | 3 | C0037286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIIQQEYEARTGRTC | 361 | O60347 | |
| ITRSFIQNRDGTYEL | 456 | Q9NWW7 | |
| REVTGYVLVALNQFR | 81 | Q15303 | |
| FVYENAKEGARNIRT | 151 | Q9BSF8 | |
| RAGIVYRFTIVNFTK | 216 | Q8NEM8 | |
| EYETTRGQILQEYRK | 566 | P55199 | |
| FTLQKVYQLETGLTR | 151 | Q8TDX6 | |
| LTKTNRIYRIFEQGK | 671 | Q14833 | |
| RIYRIFEQGKRSVSA | 676 | Q14833 | |
| YINLTSVEIRGLQKF | 5091 | Q8WXG9 | |
| RQLIDYERQLFGKST | 156 | O95147 | |
| REKYLTVQNTVRFGR | 101 | Q9Y305 | |
| RYIDNQVVSTKGERF | 246 | Q9H467 | |
| LTQGNLRYIAEKTEF | 856 | Q5JWR5 | |
| VYRVTESLQREKAGL | 351 | Q9BSW2 | |
| KELEQLFSQYGRIIT | 151 | P26378 | |
| YRLGDRVLQVSFKTN | 366 | P26378 | |
| TIIEGFKRELNYVAR | 71 | P50583 | |
| RSGYRTVKQQQTVFI | 956 | O60231 | |
| EKGLEIVYNVSDNRT | 91 | P51164 | |
| RSLDREAETIKNGIY | 531 | Q02487 | |
| TYSQIIKEGRRFNID | 216 | P24386 | |
| RITYSQIVKEGRRFN | 216 | P26374 | |
| QAIRKYGRDFQAISD | 396 | Q9UKL0 | |
| TVGIDFREKRVVYNA | 41 | O00194 | |
| KEYGQIESVRFRSLI | 206 | P42696 | |
| QEIRSLFEQYGKVLE | 16 | Q9BWF3 | |
| NEQRTLIKAYGIRFD | 306 | Q99571 | |
| NDTVDGKEIYNTIRR | 451 | P20936 | |
| GLYRRQTELQDKSEF | 796 | O75665 | |
| SNRVVLRSGKDDYIN | 1231 | Q9H3S7 | |
| ARSYNRFQIATVTEK | 226 | P28070 | |
| ITGTVLTQFDQLYRK | 651 | P29074 | |
| IRYSGFERSETEQKL | 271 | Q96LL4 | |
| QGKDFIYNRSRIDLS | 81 | O95170 | |
| EKRDGTVLRLQQYSS | 21 | Q9H867 | |
| RCQGTLEAQEYRLVK | 66 | A6NI73 | |
| KEGYIIVADRSNNRI | 616 | Q2Q1W2 | |
| TDVERIKDTYGRTQN | 2311 | Q16787 | |
| RRVNLEGIFQAVYTA | 271 | O60551 | |
| DGDTRELERTKQYVN | 136 | Q6ZNB6 | |
| GDFIIRYDVNREQSI | 256 | Q86UX2 | |
| ITRGLQKDYRTDLVF | 896 | P19823 | |
| ANRRKILETSFGYQL | 501 | P59045 | |
| VRNEFYKDTQGVILV | 81 | Q9NZQ0 | |
| QGNVDLVRFTEKRYK | 246 | P14324 | |
| QFYKQVTTVGRRLSV | 261 | Q8N370 | |
| VRNNKGRSSTYEVRL | 86 | P05161 | |
| RFIENQEKYGEASRI | 611 | Q5HYC2 | |
| SLVSRGRKFQDEITY | 3396 | Q9UPA5 | |
| VRQYTLGEFAREQER | 101 | Q8WYN3 | |
| YDIRGIQEFLDKVSQ | 176 | O43424 | |
| LQRGYTAKELNVSFI | 221 | P49585 | |
| GAFYERKIVTTDLRQ | 396 | P29122 | |
| LQRGYTAKELNVSFI | 221 | Q9Y5K3 | |
| GYSKETLRQRELQLS | 1631 | O00443 | |
| KQSRNFEDIVAERYG | 246 | Q2TBE0 | |
| REFNVGQYRRDVVKT | 71 | Q16877 | |
| QQKLYSRTGDIVEFV | 226 | P36980 | |
| VSERGSLKQQLREYI | 61 | P07492 | |
| SKRQEYLRSSGEQVL | 86 | P57055 | |
| FQGAESRTVIRYELN | 336 | Q99972 | |
| ENNKLIVRRGQSFYV | 71 | P00488 | |
| GKFNLIRRYTEISNI | 356 | Q68CQ7 | |
| ETYNNIIRSGEKICR | 2141 | P98088 | |
| QEVLQETLKSLGRYR | 36 | Q9UL42 | |
| SLFIDRTIVKGYNEN | 206 | Q6P2C8 | |
| ARGTRVVSDDNKQYL | 61 | Q9UN67 | |
| QEIRSLFEQYGKVLE | 16 | Q9BQ04 | |
| RFAYQKISNGDVILV | 321 | Q9UI10 | |
| TYQKLFGVSLQELER | 36 | O94988 | |
| QRKGTLSVNFVDLYV | 281 | P29375 | |
| KNRLYFSVQARGETD | 1216 | Q8IVE3 | |
| QTNFTKRELQVLYRG | 56 | Q9NZI2 | |
| ENKYRFGDSQQLRLV | 7146 | Q9UPN3 | |
| NSRNILYTRSEKGVI | 286 | O75694 | |
| YQRFRVLEQGLEKCT | 36 | Q6UWY5 | |
| ALRDENLKGVVYTTR | 5581 | Q96RW7 | |
| TIYLKRSNGNEERTI | 836 | Q9UMZ3 | |
| DYGDVSVRKTLRENL | 391 | Q8IUC8 | |
| YNRLTKLFDESRQGE | 121 | Q8IZS5 | |
| KLRSQEVAEGSRVYL | 276 | Q8WX93 | |
| EELRQRSQEGYRVTF | 461 | Q3MJ16 | |
| LRSRQQDKIYVGEDA | 1336 | A1KZ92 | |
| YTGKTRLARNLLQDV | 931 | Q8N0W3 | |
| ELTVQVARVYNGRLK | 26 | P57076 | |
| VTERLGEFRNEAKYV | 356 | Q9C0G6 | |
| KTNRIYRIFEQGKRS | 671 | O15303 | |
| RVSDCQRIELKQGYT | 261 | Q9Y2K7 | |
| RGFSLEEKLRSQLYQ | 66 | Q8NHM5 | |
| QNGERVERYSRKVFV | 431 | Q8NE35 | |
| QRQDRLTVGVYESAK | 31 | O75293 | |
| EDYRQFRKSVLADQG | 406 | Q9NYF8 | |
| RSITQIKYNREGDLL | 11 | Q13347 | |
| GSNIQVDEVRRLVYF | 526 | Q6V1X1 | |
| RRFVSQETGNLYIAK | 171 | Q9UQ52 | |
| LRYKTFSREQAVQTG | 96 | Q5TF58 | |
| LVKRLEFTGELNNTY | 306 | P15586 | |
| TTTQQVLDLLFKRYG | 151 | Q12967 | |
| AITDRYGRNTLIQFE | 241 | P23368 | |
| QRFSEVRNDLTGVLY | 206 | O75899 | |
| EYITKQGFTIRNTRV | 196 | Q8NC69 | |
| RGTYDILVTKDNQTR | 181 | P13861 | |
| NTLRTKEQLGYIVFS | 821 | P14735 | |
| RELAYQTFEVLRKVG | 151 | Q13206 | |
| RQRFLVDQGYSFKVI | 676 | P19447 | |
| LKEQYIDRTRVAVFG | 696 | P42658 | |
| VRDLTKGVTYFFRVQ | 1866 | Q7Z5N4 | |
| DKLRQGVTYEFRVVA | 1966 | Q7Z5N4 | |
| VRIFRAEKSYTVQSG | 1071 | P21817 | |
| KFLQDYDIRTGNTRE | 656 | Q08AD1 | |
| QVGGFINYRDSKLTR | 276 | Q02224 | |
| QIKDLFLQGAYDTVR | 226 | Q9UHL4 | |
| IISRYLREQATGAKD | 181 | Q07820 | |
| TQKLREFEEGLVSQY | 291 | Q8WTT2 | |
| ARGTRVVSDDNKQYL | 61 | Q9Y5E1 | |
| RLDQLQYDVRKGSVV | 981 | Q8N4C8 | |
| ITVDRQQQLYIFKGS | 331 | Q9H239 | |
| KIQFGLVNDTDRYLT | 11 | O14926 | |
| YRKLGSDVFSQNVIV | 506 | Q9NP80 | |
| LLGEEFRKVYQQRSE | 476 | Q8NEH6 | |
| DQKVNRFAYRTGSEI | 121 | Q96C24 | |
| VTGRIAFSLKYEQQT | 356 | Q96C24 | |
| ASIVQKRIIYFQDEG | 161 | Q9HCB6 | |
| RFRKINYKGERQTIT | 141 | Q8TEU7 | |
| SLGREVTTNQRIYFD | 406 | Q9BUR4 | |
| KREYGFISQTLQEER | 316 | Q9ULS5 | |
| ETNKETVVRYLFQTG | 1346 | Q8NF91 | |
| EKVFLRQQGSYILTV | 7611 | Q8NF91 | |
| VKGQERFSLYQTRSL | 5726 | Q8WXH0 | |
| FLYEIVSNKRNGIDV | 296 | Q9Y3Z3 | |
| QTLLLTRQRKVYGDE | 1036 | Q8IVG5 | |
| TRQRKVYGDETDTLF | 1041 | Q8IVG5 | |
| IIFGKNSDRLYDEVQ | 21 | Q0VDG4 | |
| FYTKEGIARERVENT | 476 | Q92859 | |
| VQRVFSGLYKEVNRE | 366 | Q9NPR2 | |
| VSRELNYTRQKIGEE | 136 | Q13635 | |
| ETGYRSRSAFKLIQL | 21 | Q8IY81 | |
| TDRGSFEEIYKFQRQ | 96 | P62070 | |
| SKGLATVIRYRQDDD | 456 | Q7KZF4 | |
| QSEVTRILDGKRIQY | 21 | Q9H299 | |
| RFQKRIQETEDAIGY | 671 | Q5SWA1 | |
| ARILIQERYEKFGES | 306 | Q15459 | |
| FSAQEREYIRQGKEA | 231 | Q14849 | |
| DAFRQLIYGRSSKVQ | 986 | Q8N961 | |
| AATFKGIVRAIRDYQ | 351 | P53396 | |
| ESRRLFQQILSGVDY | 126 | Q13131 | |
| FDVGKVQRYIIRISA | 781 | Q14CN2 | |
| GRIYEEQRKLEESFT | 261 | Q9NQ89 | |
| LVDNRINSYSGIKRD | 331 | Q9NQ89 | |
| FFLGQEIRTVYNREK | 326 | Q6P4Q7 | |
| VQQVEYSSIRGFLSK | 4801 | Q63HN8 | |
| DNSRTIYVVDNGLRK | 316 | Q8IWX7 | |
| DIKDSFQQVILRRYG | 121 | Q8TF32 | |
| RGRDLEQILTQYTTF | 176 | Q9HA47 | |
| RRRSFQDYTGQKITL | 111 | Q9NP64 | |
| KEGVRSRLTIYNANI | 71 | O15394 | |
| IVKQALQRYSEDRIG | 531 | Q9UH99 | |
| GDIYTQLKNLVRTFR | 526 | Q8IXW5 | |
| DVRITALKSQYEGRI | 1596 | P12270 | |
| FISGRTKQQREAEFT | 176 | Q15005 | |
| IARYGRSRNKTQDFE | 11 | Q92519 | |
| KRQVYGTDSRFSILD | 121 | Q8N3Z0 | |
| GYLKSTITQIERRFD | 61 | Q9NYB5 | |
| SVIDYFVKETRGNLR | 251 | Q9ULZ2 | |
| YRGTRDSVKTVLQDE | 101 | Q5SRE5 | |
| NTRYGTTLDEEKARV | 2676 | Q6N022 | |
| DQLASYGRKDRINSI | 686 | Q9UQD0 | |
| RAVEDYGRNIKQLAS | 1631 | P11277 | |
| YEEGSLQERQVFLKA | 446 | O43548 | |
| YTNQEKTRTFIGLEV | 161 | Q9BQ65 | |
| LYFRSQVKGETDRER | 1096 | Q9ULM0 | |
| RIQKERFGSTQEYEA | 2146 | P27708 | |
| QGIKDSFQEVILRRY | 121 | Q9H8G1 | |
| FDGRVVTRSYLEKQD | 496 | Q6PML9 | |
| QQARSYGERLKELSE | 516 | Q8N5H7 | |
| KTKFVNLYTREGQDR | 146 | Q15650 | |
| RGNSLAEQRKTVTYE | 391 | Q6ZVM7 | |
| QQVLETVAGKRSYRL | 341 | P17948 | |
| LKDYQRGLVLSTVFN | 211 | A0A286YF58 | |
| KYLGRVQEAEENFRS | 516 | Q5SRH9 | |
| IYNSEGKRLNTREFR | 86 | Q15637 | |
| RQVYSKAVNRLFGVE | 451 | O95932 | |
| GASLAENKRYREAIQ | 66 | Q6PID6 | |
| TGKEVYRLALQTREQ | 356 | P23378 | |
| GRKDSQQTTRDVLLY | 291 | Q2WGJ6 | |
| LYRTVATGRDIIDKQ | 316 | O94832 | |
| KEGVSYVFRVRAINQ | 1106 | P52179 | |
| DLQQGKTYVFRVRAV | 876 | P54296 | |
| KTYVFRVRAVNANGV | 881 | P54296 | |
| LIFSDVVQEDRGRYQ | 406 | Q14324 | |
| QDFSDINYRGIQRKV | 6466 | P20929 |